Barclays’s eXoZymes EXOZ Stock Holding History
Bought
Maintained
Sold
Other funds holding EXOZ
Barclays's EXOZ Position: Q3 2026 in Review
Barclays reduced its eXoZymes (EXOZ) stake by 89% in Q3 2026, selling an estimated $415 and leaving 8 shares worth $47. The position accounts for ﹤0.01% of the portfolio, ranked #5085.
Barclays first reported a position in EXOZ in Q2 2026 and has held it in 2 quarters since. The position peaked at $632 in Q2 2026. 9 funds tracked by Wall St. Rank hold EXOZ as of Q3 2026.
- Barclays held 8 shares of eXoZymes worth $47 as of Q3 2026.
- Barclays sold 67 eXoZymes shares in Q3 2026, an estimated $415.
- eXoZymes made up ﹤0.01% of Barclays's portfolio in Q3 2026, its #5085 holding.
- Barclays first reported a position in eXoZymes in Q2 2026 and has held it in 2 quarters since.
- Barclays's eXoZymes position peaked at $632 in Q2 2026.
- 9 funds tracked by Wall St. Rank held eXoZymes as of Q3 2026.
Based on Barclays's 13F filing for Q3 2026, filed 6 Nov 2026.